Mary McCarthy is a Sofinnova Partners Partner, helping early-stage companies develop biotech-enabled sustainable solutions. With over 24 years in chemistry and materials we value her input in the #WomenClimateLeaders network👉eib.org/en/projects/to… #InvestInWomen #IWD2024

How did #VentureCapital support Amolyt Pharma - a company offering hope to patients suffering from rare diseases? 🏥 💫€212m raised from VCs 💫$1.05bn acquisition agreement with AstraZeneca Full story ➡️investeurope.eu/about-private-… #SuccessStories #WorldHealthDay Sofinnova Partners

Our portfolio company Shockwave Medical announced its acquisition by Johnson & Johnson for $13.1 billion. For us, at Sofinnova Partners this isn’t just about financial success; it's a testament to our belief in and commitment to groundbreaking medical innovations. hubs.ly/Q02sJPRC0

Join us in congratulating two outstanding colleagues on their promotions to Partner. Underscoring our dedication to hiring and developing the best talent in the industry through a culture of learning, mentoring and leadership by example. Learn more: hubs.ly/Q02tD_MK0

On this #EarthDay, we celebrate our planet and the role of biotechnology in shaping a sustainable future. For over a decade, our Industrial Biotechnology strategy has been investing in early-stage companies that use biotechnology to make a positive environmental impact.

Congratulations to May Health a Sofinnova Partners MD Start portfolio company on its $25 million Series B financing round. We’re delighted to welcome Bpifrance and Trill Impact, in joining us as we champion May Health's mission. Learn more: hubs.ly/Q02wWVSQ0

Congrats to the entire team at Calliditas Therapeutics on their $1.05b acquisition offer by Asahi Kasei. Calliditas joins Amolyt Pharma and LimFlow SA as the 3rd successful exit in the last 6 months for Sofinnova Partners. Learn more: hubs.ly/Q02yCZ1g0

👏It's official: The Shockwave Medical team is now part of the Johnson & Johnson MedTech team. Congratulations! It’s a big moment for us to witness a decade long journey bear fruit. Learn more: hubs.ly/Q02zfycR0

Congratulations to MoonSurgical a pioneering #surgicalrobotics company created by the Sofinnova Partners medtech acceleration team on its second FDA approval for its Maestro Surgical Robotics System, enabling commercial deployment in the US and Europe. Learn more: hubs.ly/Q02zDtpC0

🌱Meiogenix a Sofinnova Partners Industrial Biotech Strategy portfolio company, announced the appointment of Ricardo Garcia de Alba as new Chief Executive Officer to propel the Company into its next growth stage. Learn more: hubs.ly/Q02C4rDv0 #AgriTech #IndustrialBiotech

Congratulations to Myricx Bio a Sofinnova Partners portfolio company on its £90m series A financing. this achievement further strengthens our conviction and our commitment to supporting the team. Learn more: hubs.ly/Q02FxHKV0 #ADCs #CancerTreatment #SeriesA

Congratulations to Asceneuron SA a Sofinnova Partners portfolio company, on its oversubscribed Series C financing of $100M. The recently raised capital will be used to advance their lead asset ASN51 into Ph. 2 for the treatment of Alzheimer’s. Learn more: hubs.ly/Q02GHWzN0

Congratulations to Elicit Plant, a Sofinnova Partners Industrial Biotech portfolio company, on its partnership with Bayer AG France. The partnership between Elicit Plant and Bayer is aimed at accelerating maize resilience in France. Learn more: hubs.ly/Q02HqLDC0

Congratulations to deepc, a Sofinnova Partners portfolio company, on the close of its financing round. We’ve been lead investors in deepc since the first tranche of their Series A round. Learn more: hubs.ly/Q02HVV930 #digitalmedicine #ai

Congratulations to MicropepTechnologies a Sofinnova Partners Industrial Biotech portfolio company, on its Series B financing and launch of its proprietary discovery platform, Krisalix. Learn more: hubs.ly/Q02HXST10 #impactinvesting #agbiotech #SeriesB

In this episode of the #DeviceTalksWeekly Podcast, Host Tom Salemi delves into the opportunities in #Women’sHealth devices with Sofinnova Partners Managing Partner Antoine Papiernik and May Health CEO Anne Morrissey. LISTEN HERE: devicetalks.com/may-health-vc-… #PCOS #OvarianHealth

We're kicking off the LSI Europe '24 Welcome Reception with a Fireside Chat featuring Josh Makower, MD and antoine papiernik at 7:00 pm on Monday, September 16th in #Sintra, #Portugal. Josh Makower joined the Sofinnova Partners team in January 2024 as an Advisory Venture Partner. As

👏It's official: The Calliditas Therapeutics team is now part of the Asahi Kasei team. This acquisition reaffirms the Sofinnova Partners Crossover’s strategy and the pharmaceutical industry’s appetite for late-stage assets. Learn more: hubs.ly/Q02Nk4_M0

Congratulations to HEPTA Medical, a Sofinnova Partners MD Start portfolio company, on the first close of its Series A round. Learn more: hubs.ly/Q02NyY130 #medtech #lungcancer #SeriesA

@BiotechTV kicked off their European tour in Paris with an overview of the European #biotech landscape with Sofinnova Partners' Chairman and Managing Partner. They discussed the capital markets, hidden gems of innovation, the start up scene in the EU vs the US, and more.